COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization

doi:10.18632/oncotarget.4250

CNU IR > Pharmacy and Science > Dept. of Cosmetic Science and institute of cosmetic science > Periodical Articles > Item 310902800/29753

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/29753

題名:	COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization
作者:	Wu, Yi-Hui Chang, Tzu-Hao Huang, Yu-Fang Chen, Chien-Chin Chou, Cheng-Yang
貢獻者:	化粧品應用與管理系
關鍵詞:	epithelial ovarian carcinoma chemoresistance collagen type XI alpha 1 Akt PDK1
日期:	2015-09
上傳時間:	2016-04-19 19:06:57 (UTC+8)
出版者:	Impact Journals Llc
摘要:	Chemoresistance to anticancer drugs substantially reduces survival in epithelial ovarian carcinoma (EOC). Here, microarray analysis showed that collagen type XI alpha 1 (COL11A1) is a chemotherapy response-associated gene. Chemoresistant cells expressed higher COL11A1 and c/EBP beta than chemosensitive cells. COL11A1 or c/EBP beta downregulation suppressed chemoresistance, whereas COL11A1 overexpression attenuated sensitivity to cisplatin and paclitaxel. The c/EBP beta binding site in the COL11A1 promoter was identified as the major determinant of cisplatin-and paclitaxel-induced COL11A1 expression. Immunoprecipitation and immunofluorescence showed that in resistant cells, Akt and PDK1 were highly expressed and that anticancer drugs enhanced binding activity between COL11A1 and PDK1 binding and attenuated PDK1 ubiquitination and degradation. Conversely, chemosensitive cells showed decreased activity of COL11A1 binding to PDK1 and increased PDK1 ubiquitination, which were reversed by COL11A1 overexpression. Analysis of 104 EOC patients showed that high COL11A1 mRNA levels are significantly associated with poor chemoresponse and clinical outcome.
關聯:	Oncotarget, v.6 n.27, pp.23748-23763
顯示於類別:	[Dept. of Cosmetic Science and institute of cosmetic science] Periodical Articles

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	1915	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....